Factors affecting infectious complications following flexible ureterorenoscopy.


Journal

Urolithiasis
ISSN: 2194-7236
Titre abrégé: Urolithiasis
Pays: Germany
ID NLM: 101602699

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 06 06 2018
accepted: 13 11 2018
pubmed: 19 11 2018
medline: 3 3 2020
entrez: 19 11 2018
Statut: ppublish

Résumé

In the present study, we aimed to clarify predictive factors that may cause postoperative infectious complications after flexible ureterorenoscopy (f-URS). In a 4-year prospective study, charts of patients who underwent f-URS between January 2014 and January 2018 for renal stone(s) in a tertiary academic center were reviewed. A standardized f-URS procedure was performed for all patients. Post-operative infectious complications including fever, sepsis and septic shock were categorized into same group. Patients with and without infectious complications were compared in the terms of preoperative, operative and post operative characteristics. In total, 463 patients who did not face infectious complications and 31 patients who faced infectious complications were enrolled into the study. The mean age was significantly lower in patients who did face infectious complications (34.8 vs 44.7 years old, p < 0.001). On the other hand, presence of renal abnormality was significantly more common in patients with infectious complications (12.3% vs 35.5%, p < 0.001). The mean operation time was 65.3 min in patients with infectious complications and significantly longer when compared with patients who did not face infectious complication (47.8 min, p < 0.001). Stone-free rate was significantly higher in patients without infectious complications (85.3% vs 77.5, p = 0.009). Multivariate regression analysis revealed that longer operation time ≥ 60 min, presence of renal abnormality and age ≤ 40 years were predictive factors for infectious complications following f-URS. The present study has demonstrated that operation time ≥ 60 min, presence of renal abnormality and patients with ≤ 40 years were significantly associated with infectious complications following f-URS.

Identifiants

pubmed: 30448869
doi: 10.1007/s00240-018-1098-y
pii: 10.1007/s00240-018-1098-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

481-486

Références

Urology. 2003 Apr;61(4):713-8
pubmed: 12670551
J Urol. 2007 Jan;177(1):168-73; discussion173
pubmed: 17162030
J Endourol. 2008 Sep;22(9):2147-51
pubmed: 18811571
Urol J. 2010 Winter;7(1):17-21
pubmed: 20209450
J Endourol. 2010 Oct;24(10):1583-8
pubmed: 20629566
World J Urol. 2011 Dec;29(6):755-9
pubmed: 22037633
J Endourol. 2012 Aug;26(8):996-1001
pubmed: 22494028
Urolithiasis. 2013 Feb;41(1):73-8
pubmed: 23532427
Urolithiasis. 2013 Feb;41(1):79-83
pubmed: 23532428
Urolithiasis. 2015 Feb;43(1):77-82
pubmed: 25161087
Urology. 2014 Dec;84(6):1285-9
pubmed: 25288574
World J Urol. 2016 Mar;34(3):305-10
pubmed: 26210344
Int J Clin Exp Med. 2015 Jul 15;8(7):11252-9
pubmed: 26379932
J Endourol. 2016 Jan;30(1):49-55
pubmed: 26381037
Rev Urol. 2016;18(1):10-4
pubmed: 27162507
Int Urol Nephrol. 2016 Nov;48(11):1757-1762
pubmed: 27443315
Urol Ann. 2016 Oct-Dec;8(4):434-438
pubmed: 28057987
Turk J Urol. 2017 Sep;43(3):252-260
pubmed: 28861294
J Urol. 1993 Jun;149(6):1576-85
pubmed: 8501816

Auteurs

Faruk Ozgor (F)

Urology Department, Haseki Training and Research Hospital, Millet Street, Fatih, Istanbul, Turkey. md.farukozgor@yahoo.com.

Murat Sahan (M)

Urology Department, Haseki Training and Research Hospital, Millet Street, Fatih, Istanbul, Turkey.

Alkan Cubuk (A)

Urology Department, Haseki Training and Research Hospital, Millet Street, Fatih, Istanbul, Turkey.

Mazhar Ortac (M)

Urology Department, Haseki Training and Research Hospital, Millet Street, Fatih, Istanbul, Turkey.

Ali Ayranci (A)

Urology Department, Haseki Training and Research Hospital, Millet Street, Fatih, Istanbul, Turkey.

Omer Sarilar (O)

Urology Department, Haseki Training and Research Hospital, Millet Street, Fatih, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH